These five short videos look at the challenges that five pharmacovigilance professionals face in their respective countries.
In addition to “Going Further Together”, the 25-minute film made by Miran Media for UMC, we have also created 5 shorter films as mentioned in the previous blog post. These five short films each start with UMC in Sweden and then jump to Cabo Verde, Morocco, Singapore, Peru, and Croatia respectively. Every country faces unique challenges and makes progress in different areas; each providing insight into a different aspect of global patient safety.
In Cape Verde, Djamila Reis, President of Agência de Regulação e Supervisão dos Produtos Farmacêuticos e Alimentares (ARFA), shows why face to face advocacy and education must be placed at the forefront of public health missions to inform and protect the public.
Dr Darko Krnić, Head of the Pharmacovigilance Department at Agency for Medicinal Products and Medical Devices in Croatia (HALMED) says that he is proud of his team and that they, like other professionals he has met around the world, are all working for the same goal: safer healthcare for everyone. In an age of “fake news” Dr Krnić stresses the threat to children’s health posed by misinformation about vaccines.
Dr Rachida Bencheikh, Director of Centre Anti Poison et de Pharmacovigilance in Morocco (CAPM) realises that more robust strategies are required in the struggle against the threat of harmful medications. That’s why she has turned to the radio airwaves to spread knowledge on safer use of medicines and build trust among the public.
Dr Dorothy Toh, Assistant Group Director of Singapore’s Health Sciences Authority (HSA) talks about how medication can be personalised with genetic data from patients. A high-tech society like Singapore, which also has a genetically diverse population, can employ the latest methods in genetic science to ensure patients receive safer healthcare.
Peruvian pharmacist Magaly Tito Yépez has to think creatively to overcome the challenge of gathering data on patient safety and educating patients and healthcare workers in a country which stretches from the towering Andes to the inaccessible Amazon jungle. Poverty and lack of access to medications in Peru also lead to the sale of low quality medicines which can be dangerous for patients.